Modulation of Blood Pressure by Central Melanocortinergic Pathways

Cited by (490)

Items 101–200 of 490

1. Obesity-Induced Hypertension: Brain Signaling Pathways
   Jussara Marcia do Carmo, Alexandre A. da Silva, Zhen Wang, Taolin Fang, Nicola Aberdein, Cecilia E. P. de Lara Rodriguez, John Edward Hall · 2016 · Current Hypertension Reports
2. Type 2 diabetes partitioned polygenic scores associate with disease outcomes in 454,193 individuals across 13 cohorts
   DiCorpo, Daniel, LeClair, Jessica, Cole, Joanne B., Sarnowski, Chloé, Ahmadizar, Fariba, Bielak, Lawrence F., Blokstra, Anneke, Bottinger, Erwin P., Chaker, Layal, Chen, Yii-Der I. et al. · 2022 · Diabetes Care
3. Natural History of Obesity Due to POMC, PCSK1, and LEPR Deficiency and the Impact of Setmelanotide
   Martin Wabitsch, I. Sadaf Farooqi, Christa E. Flück, Nataša Bratina, Usha G. Mallya, Murray W Stewart, Jill Garrison, Erica L T van den Akker, Peter Kühnen · 2022 · Journal of the Endocrine Society
4. Implication of the melanocortin-3 receptor in the regulation of food intake
   Boman G. Irani, Zhimin Xiang, HOSSEIN N. YARANDI, Jerry Ryan Holder, Marcus C. Moore, Rayna M. Bauzo, Bettina Proneth, Amanda M. Shaw, William J. Millard, James Bradley Chambers et al. · 2011 · European Journal of Pharmacology
5. Divergent effects of central melanocortin signalling on fat and sucrose preference in humans
   Agatha A. van der Klaauw, Julia M. Keogh, Elana Henning, Cheryl Stephenson, Sarah Kelway, Victoria M. Trowse, Naresh Subramanian, Stephen O’Rahilly, Paul Charles Fletcher, I. Sadaf Farooqi · 2016 · Nature Communications
6. The Sympathetic Nervous System in Hypertension: Roadmap Update of a Long Journey
   Guido M. Grassi · 2021 · American Journal of Hypertension
7. Greater Impact of Melanocortin-4 Receptor Deficiency on Rates of Growth and Risk of Type 2 Diabetes During Childhood Compared With Adulthood in Pima Indians
   Marie S. Thearle, Yunhua L. Muller, Robert L. Hanson, Meghan Mullins, Maryam Abdussamad, John Tran, William C. Knowler, Clifton Bogardus, Jonathan A. Krakoff, Leslie J. Baier · 2011 · Diabetes
8. Prevalence and phenotypic characterization of MC4R variants in a large pediatric cohort
   Heike Vollbach, S. Brandt, Georgia Lahr, Christian Denzer, Julia von Schnurbein, Klaus‐Michael Debatin, Martin Wabitsch · 2016 · International Journal of Obesity
9. Experimental Hyperleptinemia Acutely Increases Vasoconstrictory Sympathetic Nerve Activity in Healthy Humans
   Machleidt, Felix, Simon, Paul, Krapalis, Alexander F., Hallschmid, Manfred, Lehnert, Hendrik, Sayk, Friedhelm · 2013 · The Journal of Clinical Endocrinology & Metabolism
10. Regulation of lipid metabolism by energy availability: a role for the central nervous system
    Rubén Nogueiras, Miguel López, Carlos Diéguez · 2009 · Obesity Reviews
11. Chapter 4 Melanocortin‐4 Receptor Mutations In Obesity
    Ferruccio Santini, Margherita Maffei, Caterina Pelosini, Guido Salvetti, Giovanna Scartabelli, Aldo Pinchera · 2009 · Advances in clinical chemistry
12. Melanocortin 4 receptor distribution in the human hypothalamus
    Jacqueline E. Siljee, Unga A. Unmehopa, Andries Kalsbeek, Dick Frans Swaab, Eric Fliers, Anneke Alkemade · 2012 · European Journal of Endocrinology
13. Obesity and Cardiovascular Disease: The Emerging Role of Inflammation
    Rana Tarek Mohamed Khafagy, Satya Dash · 2021 · Frontiers in Cardiovascular Medicine
14. Neurochemical Characterization of Brainstem Pro-Opiomelanocortin Cells
    Teodora R. Georgescu, David J. Lyons, Barbora Doslikova, Ana Paula García, Oliver J. Marston, Luke K. Burke, Raffaella Chianese, Brian Lam, Giles S.H. Yeo, Justin J. Rochford et al. · 2020 · Endocrinology
15. Effects of FTO RS9939906 and MC4R RS17782313 on obesity, type 2 diabetes mellitus and blood pressure in patients with hypertension
    Aline Marcadenti, Flávio Danni Fuchs, Úrsula da Silveira Matte, Fernanda Sperb, Leila Beltrami Moreira, Sandra Cristina Pereira Costa Fuchs · 2013 · Cardiovascular Diabetology
16. The Role of the Melanocortin System in Metabolic Disease: New Developments and Advances
    Jennifer Wootton Hill, Latrice D. Faulkner · 2016 · Neuroendocrinology
17. Genetic, molecular and physiological insights into human obesity
    I. Sadaf Farooqi · 2011 · European Journal of Clinical Investigation
18. Pathophysiology of melanocortin receptors and their accessory proteins
    T.V. Novoselova, Li F. Chan, Adrian Clark · 2018 · Best Practice & Research Clinical Endocrinology & Metabolism
19. Neuroanatomical organization and functional roles of PVN MC4R pathways in physiological and behavioral regulations
    Uday Singh, Jingwei Jiang, Kenji Saito, Brandon A. Toth, Jacob E. Dickey, Samuel R. Rodeghiero, Yue Deng, Guorui Deng, Baojian Xue, Zhiyong Zhu et al. · 2021 · Molecular Metabolism
20. Hypothalamic POMC Deficiency Improves Glucose Tolerance Despite Insulin Resistance by Increasing Glycosuria
    Kavaljit H. Chhabra, Jessica M. Adams, Brian Fagel, Daniel D. Lam, Nathan Qi, Marcelo Rubinstein, Malcolm James Low · 2015 · Diabetes
21. Leveraging Melanocortin Pathways to Treat Glomerular Diseases
    Rujun Gong · 2014 · Advances in Chronic Kidney Disease
22. Impact of Variation Near MC4R on Whole‐body Fat Distribution, Liver Fat, and Weight Loss
    Axel Haupt, Claus Thamer, Martin Heni, Otto Tschritter, Jürgen Machann, Fritz Schick, Fausto E Machicao, Hans‐Ulrich Häring, Harald Staiger, Andreas Fritsche · 2009 · Obesity
23. Pharmacological Characterization of 30 Human Melanocortin-4 Receptor Polymorphisms with the Endogenous Proopiomelanocortin-Derived Agonists, Synthetic Agonists, and the Endogenous Agouti-Related Protein Antagonist,
    Zhimin Xiang, Bettina Proneth, Marvin L. S. Dirain, Sally A. Litherland, Carrie Haskell‐Luevano · 2010 · Biochemistry
24. Astragaloside IV Prevents Obesity-Associated Hypertension by Improving Pro-Inflammatory Reaction and Leptin Resistance.
    Ping Jiang, Dufang Ma, Xue Wang, Yongcheng Wang, Yuxin Bi, Yang Jl, Xuebing Wang, Xiao Li · 2018 · PubMed Central
25. Role of the Sympathetic Nervous System in Hypertension and Hypertension-Related Cardiovascular Disease
    Gino Seravalle, Giuseppe Mancia, Guido M. Grassi · 2014 · High Blood Pressure & Cardiovascular Prevention
26. The nonhuman primate as a model for type 2 diabetes
    Lynley D. Pound, Paul Kievit, Kevin L. Grove · 2014 · Current Opinion in Endocrinology Diabetes and Obesity
27. Eating Behavior, Low-Frequency Functional Mutations in the Melanocortin-4 Receptor (MC4R) Gene, and Outcomes of Bariatric Operations: A 6-Year Prospective Study
    Amélie Bonnefond, Ramsi Keller, David Meyre, Fanny Stutzmann, Dorothée Thuillier, Dimitre G. Stefanov, Philippe Froguel, Fritz Horber, John G. Kral · 2016 · Diabetes Care
28. Pediatric Obesity: Etiology and Treatment
    Melissa K. Crocker, Jack Adam Yanovski · 2011 · Pediatric Clinics of North America
29. Hypertension in obesity: is leptin the culprit?
    Stephanie E. Simonds, Michael Alexander Cowley · 2013 · Trends in Neurosciences
30. Primary hypertension is a disease of premature vascular aging associated with neuro-immuno-metabolic abnormalities
    Mieczysław Litwin, Janusz Feber, Anna Niemirska, Jacek Michałkiewicz · 2015 · Pediatric Nephrology
31. Biased signaling initiated by agouti-related peptide through human melanocortin-3 and -4 receptors
    Yang Zhao, Ya‐Xiong Tao · 2016 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
32. Obesity, Sympathetic Overdrive, and Hypertension
    Kamal Rahmouni · 2010 · Hypertension
33. The Brain Melanocortin System, Sympathetic Control, and Obesity Hypertension
    da Silva, Alexandre A., do Carmo, Jussara M., Wang, Zhen, Hall, John E. · 2014 · Physiology
34. The neurobiology of overeating
    Garret D. Stuber, Valérie Schwitzgebel, Christian Lüscher · 2025 · Neuron
35. Neuroendocrinological and Epigenetic Mechanisms Subserving Autonomic Imbalance and HPA Dysfunction in the Metabolic Syndrome
    Erwin Lemche, Олег Чабан, Alexandra V. Lemche · 2016 · Frontiers in Neuroscience
36. Reduced renal sympathetic nerve activity contributes to elevated glycosuria and improved glucose tolerance in hypothalamus-specific Pomc knockout mice
    Kavaljit H. Chhabra, Donald A. Morgan, Benjamin P. Tooke, Jessica M. Adams, Kamal Rahmouni, Malcolm James Low · 2017 · Molecular Metabolism
37. Energy expenditure in obese children with pseudohypoparathyroidism type 1a
    Ashley Hall Shoemaker, Jefferson P. Lomenick, Benjamin R. Saville, W Wang, Maciej S. Buchowski, Roger D. Cone · 2012 · International Journal of Obesity
38. Prolylcarboxypeptidase deficiency is associated with increased blood pressure, glomerular lesions, and cardiac dysfunction independent of altered circulating and cardiac angiotensin II
    Christoph Maier, Ines Schadock, Philipp Konstantin Haber, Jan A Wysocki, Minghao Ye, Yashpal S. Kanwar, Chris A. Flask, Xin Yu, Brian D. Hoit, Gregory N. Adams et al. · 2017 · Journal of Molecular Medicine
39. Leptin, Obesity, and Hypertension: A Review of Pathogenetic Mechanisms
    Song Lu, Abayomi O. Akanji · 2020 · Metabolic Syndrome and Related Disorders
40. Mouse models and the interpretation of human GWAS in type 2 diabetes and obesity
    Roger Cox, CHRISTOPHER D. CHURCH · 2011 · Disease Models & Mechanisms
41. An in Vitro and in Vivo Investigation of Bivalent Ligands That Display Preferential Binding and Functional Activity for Different Melanocortin Receptor Homodimers
    Cody J. Lensing, Katie T. Freeman, Sathya M. Schnell, Danielle N. Adank, Robert Charles Speth, Carrie Haskell‐Luevano · 2016 · Journal of Medicinal Chemistry
42. Obesity Hypertension: The Regulatory Role of Leptin
    Shilpa Kshatriya, Kan Liu, Ali Salah, Tamás Szombathy, Ronald H. Freeman, Garry P. Reams, Robert M. Spear, Daniel Villarreal · 2011 · International Journal of Hypertension
43. Combined inhibition of PI3Kβ and PI3Kγ reduces fat mass by enhancing α-MSH–dependent sympathetic drive
    Alessia Perino, Martina Beretta, Ana Kilić, Alessandra Ghigo, Daniela Carnevale, Ivan Enrico Repetto, Laura Braccini, Dario Livio Longo, Michaela Liebig‐Gonglach, Tania Zaglia et al. · 2014 · Science Signaling
44. MECHANISMS IN ENDOCRINOLOGY: Update on treatments for patients with genetic obesity
    Christine Poitou, Héléna Mosbah, Karine Clément · 2020 · European Journal of Endocrinology
45. Characterization of murine melanocortin receptors mediating adipocyte lipolysis and examination of signalling pathways involved
    Cathrine Laustrup Møller, Kirsten Raun, Marianne Lambert Jacobsen, Thomas Åskov Pedersen, Birgitte Holst, Kilian W. Conde‐Frieboes, Birgitte Schjellerup Wulff · 2011 · Molecular and Cellular Endocrinology
46. Metabolic Disease Drug Discovery— “Hitting the Target” Is Easier Said Than Done
    David E. Moller · 2012 · Cell Metabolism
47. Melanocortin‐4 receptor complexity in energy homeostasis,obesity and drug development strategies
    Munazza Tamkeen Fatima, Ikhlak Ahmed, Khalid Adnan Fakhro, Ammira Al‐Shabeeb Akil · 2021 · Diabetes Obesity and Metabolism
48. Defining the neural basis of appetite and obesity: from genes to behaviour
    I. Sadaf Farooqi · 2014 · Clinical Medicine
49. Hypertension in obesity
    Michael F. Mendoza, Sergey M. Kachur, Carl J. Lavie · 2020 · Current Opinion in Cardiology
50. Development of a high throughput screen for allosteric modulators of melanocortin-4 receptor signaling using a real time cAMP assay
    Jacques Pantel, Savannah Y. Williams, Dehui Mi, Julien A. Sebag, Jackie D. Corbin, C. David Weaver, Roger D. Cone · 2011 · European Journal of Pharmacology
51. Disorders of Blood Pressure Regulation—Role of Catecholamine Biosynthesis, Release, and Metabolism
    Gemma E. Currie, E. Marie Freel, Colin Graham Perry, Anna F. Dominiczak · 2011 · Current Hypertension Reports
52. Novel pharmacological MC4R agonists can efficiently activate mutated MC4R from obese patient with impaired endogenous agonist response
    Pierre Roubert, Béatrice Dubern, Pascale Plas, Cécile Lubrano-Berthelier, Rohia Alihi, Florence Auger, Daniel B. DeOliveira, Jesse Z. Dong, Arnaud Basdevant, Christophe Thurieau et al. · 2010 · Journal of Endocrinology
53. Melanocortin-3 Receptors and Metabolic Homeostasis
    Karima Begriche, Girardet Clemence, Patricia H. McDonald, Andrew A. Butler · 2013 · Progress in molecular biology and translational science
54. Melanocortin-4 Receptors and Sympathetic Nervous System Activation in Hypertension
    Alexandre A. da Silva, Jussara Marcia do Carmo, Zhen Wang, John Edward Hall · 2019 · Current Hypertension Reports
55. Hypothalamic MC4R regulates glucose homeostasis through adrenaline-mediated control of glucose reabsorption via renal GLUT2 in mice
    Letícia Maria de Souza Cordeiro, Arwa Elsheikh, Nagavardhini Devisetty, Donald A. Morgan, Steven N. Ebert, Kamal Rahmouni, Kavaljit H. Chhabra · 2020 · Diabetologia
56. A fragment of the Escherichia coli ClpB heat-shock protein is a micromolar melanocortin 1 receptor agonist
    Ericson, Mark D., Schnell, Sathya M., Freeman, Katie T., Haskell-Luevano, Carrie · 2015 · Bioorganic & Medicinal Chemistry Letters
57. Investigation of safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple doses of a long‐acting α‐MSH analog in healthy overweight and obese subjects
    Jane E. Royalty, Gitte Konradsen, Ole Eskerod, Birgitte Schjellerup Wulff, Birgit Sehested Hansen · 2013 · The Journal of Clinical Pharmacology
58. Weight loss through smoking
    Randy J. Seeley, Darleen A. Sandoval · 2011 · Nature
59. Activation of the central melanocortin system contributes to the increased arterial pressure in obese Zucker rats
    do Carmo, Jussara M., da Silva, Alexandre A., Rushing, John S., Hall, John E. · 2012 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
60. A human obesity-associated MC4R mutation with defective Gq/11α signaling leads to hyperphagia in mice
    Metzger, Peter J., Zhang, Aileen, Carlson, Bradley A., Sun, Hui, Cui, Zhenzhong, Li, Yongqi, Jahnke, Marshal T., Layton, Daniel R., Gupta, Meenakshi B., Liu, Naili et al. · 2024 · Journal of Clinical Investigation
61. Variation at the melanocortin 4 receptor gene and response to weight‐loss interventions in the diabetes prevention program
    Qing Pan, Linda M. Delahanty, Kathleen A. Jablonski, William C. Knowler, Steven E. Kahn, José C. Florez, Paul W. Franks · 2013 · Obesity
62. Biased signaling in naturally occurring mutations of G protein-coupled receptors associated with diverse human diseases
    Li-Kun Yang, Zhi-Shuai Hou, Ya‐Xiong Tao · 2020 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
63. Neuroanatomical determinants of the sympathetic nerve responses evoked by leptin
    Shannon M. Harlan, Kamal Rahmouni · 2012 · Clinical Autonomic Research
64. Differential control of metabolic and cardiovascular functions by melanocortin-4 receptors in proopiomelanocortin neurons
    do Carmo, Jussara M., da Silva, Alexandre A., Rushing, John S., Pace, Benjamin, Hall, John E. · 2013 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
65. Obesity treatment effect in Danish children and adolescents carrying Melanocortin-4 Receptor mutations
    Trier, Cæcilie, Hollensted, Mette, Schnurr, Theresia M., Lund, Morten Asp Vonsild, Nielsen, Tenna Ruest Haarmark, Rui, Gao, Andersson, Ehm Astrid, Svendstrup, Mathilde, Bille, Dorthe Sadowa, Gjesing, Anette P. et al. · 2021 · International Journal of Obesity
66. Role of the brain melanocortins in blood pressure regulation
    do Carmo, Jussara M., da Silva, Alexandre A., Wang, Zhen, Fang, Taolin, Aberdein, Nicola, Perez de Lara, Cecilia E., Hall, John E. · 2017 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
67. Conditional Expression ofPomcin theLepr-Positive Subpopulation of POMC Neurons Is Sufficient for Normal Energy Homeostasis and Metabolism
    Daniel D. Lam, Courtney A. Attard, Aaron J. Mercer, Martin Grosvenor Myers, Marcelo Rubinstein, Malcolm James Low · 2015 · Endocrinology
68. Neuropeptides in Obesity and Metabolic Disease
    Agatha A. van der Klaauw · 2017 · Clinical Chemistry
69. Genetic, molecular and physiological mechanisms involved in human obesity: Society for Endocrinology Medal Lecture 2012
    Farooqi, Sadaf I. · 2015 · Clinical Endocrinology
70. Control of metabolic and cardiovascular function by the leptin–brain melanocortin pathway
    do Carmo, Jussara M., da Silva, Alexandre A., Dubinion, John, Sessums, Price O., Ebaady, Sabira H., Wang, Zhen, Hall, John E. · 2013 · IUBMB Life
71. Central Nervous System Dysfunction in Obesity-Induced Hypertension
    Geoffrey A. Head, Kyungjoon Lim, Benjamin Barzel, Sandra L. Burke, Pamela J. Davern · 2014 · Current Hypertension Reports
72. Understanding melanocortin-4 receptor control of neuronal circuits: Toward novel therapeutics for obesity syndrome
    Sang Hyeon Ju, Gyu‐Bon Cho, Jong‐Woo Sohn · 2018 · Pharmacological Research
73. The Impacts of Obesity on the Cardiovascular and Renal Systems: Cascade of Events and Therapeutic Approaches
    Zohreh Soltani, Vaughn Washco, Stephen Morse, Efrain Reisin · 2015 · Current Hypertension Reports
74. Common Variants Near MC4R: Exploring Gender Effects in Overweight and Obese Children and Adolescents Participating in a Lifestyle Intervention
    Carla Ivane Ganz Vogel, Tanja Boes, Thomas Reinehr, Christian Ludwig Roth, Susann Scherag, André Scherag, Johannes Hebebrand, Anke Hinney · 2011 · Obesity Facts
75. Curbing Inflammation through Endogenous Pathways: Focus on Melanocortin Peptides
    Tazeen J. Ahmed, Trinidad Montero‐Melendez, Mauro Perretti, Costantino Pitzalis · 2013 · International Journal of Inflammation
76. Activation of hypothalamic AgRP and POMC neurons evokes disparate sympathetic and cardiovascular responses
    Jingwei Jiang, Donald A. Morgan, Huxing Cui, Kamal Rahmouni · 2020 · American Journal of Physiology-Heart and Circulatory Physiology
77. Biphasic Effect of Melanocortin Agonists on Metabolic Rate and Body Temperature
    Beth Lute, William Jou, Dalya M. Lateef, Margalit Goldgof, Cuiying Xiao, Ramón A. Piñol, Alexxai V. Kravitz, Nicole Miller, Yuning George Huang, Girardet Clemence et al. · 2014 · Cell Metabolism
78. Naturally occurring mutations in G protein-coupled receptors associated with obesity and type 2 diabetes mellitus
    Liu, Ting, Ji, Ren-Lei, Tao, Ya-Xiong · 2022 · Pharmacology & Therapeutics
79. Deciphering the neural signature of human cardiovascular regulation
    Jorge Manuel, Natalia Färber, Darius A. Gerlach, Karsten Heusser, Jens Jordan, Jens Tank, Florian Beißner · 2020 · eLife
80. Update on melanocortin interventions for cachexia: Progress toward clinical application
    Mark Daniel DeBoer · 2009 · Nutrition
81. Control of respiratory and cardiovascular functions by leptin
    Mirian Bassi, Werner Issao Furuya, Daniel Breseghello Zoccal, José Vanderlei Menani, Eduardo Colombari, John Edward Hall, Alexandre A. da Silva, Jussara Marcia do Carmo, Débora S.A. Colombari · 2015 · Life Sciences
82. CNS-targeting pharmacological interventions for the metabolic syndrome
    Kerstin Stemmer, Timo D. Müller, Richard D. DiMarchi, Paul T. Pfluger, Matthias H. Tschöp · 2019 · Journal of Clinical Investigation
83. Effects of metabolic state on the regulation of melanocortin circuits
    Linh Lieu, Dominic Chau, Sadia Afrin, Yanbin Dong, Amber L. Alhadeff, J. Nicholas Betley, Kevin W. Williams · 2020 · Physiology & Behavior
84. Melanocortin receptor-mediated effects on obesity are distributed over specific hypothalamic regions
    M.W.A. de Backer, Susanne Eva la Fleur, Maike A. D. Brans, Andrea J. van Rozen, Mieneke C. M. Luijendijk, Myrte Merkestein, Keith M. Garner, Esther M. van der Zwaal, Roger A.H. Adan · 2010 · International Journal of Obesity
85. Science of self-preservation: how melanocortin action in the brain modulates body weight, blood pressure, and ischemic damage
    Corander, Marcus P., Fenech, Matthew, Coll, Anthony P. · 2009 · Circulation
86. Hypertension: Physiology and Pathophysiology
    John Edward Hall, Joey P. Granger, Jussara Marcia do Carmo, Alexandre A. da Silva, John Harvey Dubinion, Eric Matthew George, Shereen Hamza, Joshua S. Speed, Michael E. Hall · 2012 · Comprehensive physiology
87. Genetic aspects of human obesity
    Rachel Larder, Chung Thong Lim, Anthony P. Coll · 2014 · Handbook of clinical neurology
88. Monogenic human obesity syndromes
    I. Sadaf Farooqi · 2021 · Handbook of clinical neurology
89. Successful methylphenidate treatment of early onset extreme obesity in a child with a melanocortin-4 receptor gene mutation and attention deficit/hyperactivity disorder
    Özgür Albayrak, Beate Albrecht, Susann Scherag, Nikolaus Barth, Anke Hinney, Johannes Hebebrand · 2011 · European Journal of Pharmacology
90. Genetics of obesity: can an old dog teach us new tricks?
    Giles S.H. Yeo · 2016 · Diabetologia
91. Obesity-induced changes in kidney mitochondria and endoplasmic reticulum in the presence or absence of leptin
    Shankar Munusamy, Jussara Marcia do Carmo, Jonathan P. Hosler, John Edward Hall · 2015 · American Journal of Physiology-Renal Physiology
92. Inducible Neuronal Inactivation of Sim1 in Adult Mice Causes Hyperphagic Obesity
    Kristen P. Tolson, Terry Gemelli, Donna Meyer, Umar Yazdani, Julia Kozlitina, Andrew R. Zinn · 2014 · Endocrinology
93. Identification of the MC4R start lost mutation in a morbidly obese Brazilian patient
    Ana Carolina Proença da Fonseca, Gabriella de Medeiros Abreu, Verônica Marques Zembrzuski, Mário Campos, João Régis Ivar Carneiro, Fernanda Cristina Carvalho Mattos Magno, Eliane Lopes Rosado, José Firmino Nogueira Neto, Giselda Maria Kalil de Cabello, Pedro Hernán Cabello · 2019 · Diabetes Metabolic Syndrome and Obesity
94. Sympathetic activity in obesity: a brief review of methods and supportive data
    Gavin William Lambert, Markus Peter Schlaich, Nina Eikelis, Élisabeth Lambert · 2019 · Annals of the New York Academy of Sciences
95. The impact of the metabolic syndrome – but not of hypertension – on all-cause mortality disappears in the elderly
    Frédérique Thomas, Bruno Pannier, Athanase Bénétos, Ulrich M. Vischer · 2010 · Journal of Hypertension
96. Pathogenesis of Hypertension
    Michael E. Hall, John Edward Hall · 2017 · Elsevier eBooks
97. Leptin and Aldosterone
    Jessica Faulkner, Eric J. Belin de Chantemèle · 2018 · Vitamins and hormones
98. Recent Advances in Hypertension
    Vanessa Oliveira, Anne E. Kwitek, Curt D. Sigmund, Lisa Linda Morselli, Justin L. Grobe · 2021 · Hypertension
99. Oxytocin as an Anti-obesity Treatment
    Jingjing Niu, Jenny Tong, James Ernest Blevins · 2021 · Frontiers in Neuroscience
100. Combined amylin–leptin treatment lowers blood pressure and adiposity in lean and obese rats
     R. Seth, W. David Knight, J. M. Overton · 2010 · International Journal of Obesity